Search Results
CML Patient Insights
Outcomes of patients with CML with no molecular response within two years of TKI therapy
The current standard of care in CML and insights into the use of first- and second-generation TKIs
Halving the TKI dose safe, cost effective in CML patients with stable remissions
CML molecular monitoring: Practical advice
A patient’s perspective on Chronic Myeloid Leukemia (CML)
Response Monitoring of Patients With CML Treated With TKIs
Nigel's story: Chronic Myeloid Leukaemia (CML)
Managing CML in emerging regions: some problems and perspectives
World CML Day webinar with Professor Tim Hughes
The patient's and patient advocate's perspective on achieving a cure in CML
Dosing strategy of ponatinib in CP-CML: insights from the OPTIC trial
